TAI Diagnostics, a developer of diagnostic tests for monitoring the health of transplanted organs, said on Monday that it has closed a $10 million Series A preferred equity financing.
{iframe}https://www.genomeweb.com/business-news/tai-diagnostics-closes-10m-series-financing-partners-united-therapeutics{/iframe}